← All trials
NCT01618617
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2012
- Primary completion
- Mar 1, 2013
- Completion date
- Mar 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 81
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Renew Life Formulas IncLead sponsor
- Stanford UniversityOverall official - principal investigator
- Sprim ConsultingCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.